ProfileGDS4718 / 237478_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 29% 40% 31% 40% 38% 45% 42% 39% 36% 33% 31% 37% 43% 41% 44% 30% 37% 41% 47% 46% 44% 39% 33% 32% 35% 44% 35% 42% 39% 51% 42% 45% 38% 40% 41% 32% 37% 40% 40% 36% 34% 44% 40% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5252929
GSM549102patient 115, normal, homogenized [OPG study]5.0334140
GSM549104patient 119, normal, homogenized [OPG study]4.5795431
GSM549108patient 138, normal, homogenized [OPG study]5.0576240
GSM549119patient 077, normal, homogenized [OPG study]4.8869838
GSM549133patient 032, cancer, homogenized [OPG study]5.1983845
GSM549139patient 042, cancer, homogenized [OPG study]5.0546742
GSM549099patient 107, normal, homogenized [OPG study]4.9575439
GSM549109patient 139, normal, homogenized [OPG study]4.813536
GSM549110patient 046, normal, homogenized [OPG study]4.6890933
GSM549114patient 063, normal, homogenized [OPG study]4.5353431
GSM549122patient 082, normal, homogenized [OPG study]4.8568137
GSM549134patient 033, cancer, homogenized [OPG study]5.1509943
GSM549136patient 036, cancer, homogenized [OPG study]4.9817541
GSM549140patient 044, cancer, homogenized [OPG study]5.1417244
GSM549111patient 047, normal, homogenized [OPG study]4.5249530
GSM549113patient 057, normal, homogenized [OPG study]4.8062337
GSM549132patient 031, cancer, homogenized [OPG study]5.0461441
GSM549137patient 038, cancer, homogenized [OPG study]5.3086947
GSM549142patient 047, cancer, homogenized [OPG study]5.4027946
GSM549100patient 110, normal, homogenized [OPG study]5.2360144
GSM549107patient 135, normal, homogenized [OPG study]4.9333139
GSM549115patient 068, normal, homogenized [OPG study]4.6095433
GSM549116patient 072, normal, homogenized [OPG study]4.6033832
GSM549120patient 078, normal, homogenized [OPG study]4.7753335
GSM549131patient 030, cancer, homogenized [OPG study]5.1278244
GSM549118patient 074, normal, homogenized [OPG study]4.7363435
GSM549129patient 027, cancer, homogenized [OPG study]5.1033242
GSM549123patient 088, normal, homogenized [OPG study]4.9383239
GSM549124patient 006, cancer, homogenized [OPG study]5.6144651
GSM549126patient 015, cancer, homogenized [OPG study]5.091342
GSM549128patient 025, cancer, homogenized [OPG study]5.222745
GSM549103patient 117, normal, homogenized [OPG study]4.9829538
GSM549117patient 073, normal, homogenized [OPG study]4.9685740
GSM549138patient 041, cancer, homogenized [OPG study]5.0270941
GSM549141patient 045, cancer, homogenized [OPG study]4.5689632
GSM549130patient 028, cancer, homogenized [OPG study]4.8642137
GSM549101patient 111, normal, homogenized [OPG study]5.0365240
GSM549105patient 128, normal, homogenized [OPG study]4.9927940
GSM549106patient 134, normal, homogenized [OPG study]4.759836
GSM549112patient 048, normal, homogenized [OPG study]4.713734
GSM549125patient 011, cancer, homogenized [OPG study]5.1918544
GSM549127patient 024, cancer, homogenized [OPG study]4.9633340
GSM549135patient 035, cancer, homogenized [OPG study]5.1332344